Should we, and how to, optimize cefiderocol administration during severe nosocomial pneumonia due to carbapenem-resistant Acinetobacter baumanii? A viewpoint
Objectives: Acinetobacter baumannii is classified by the centre for Disease Control and Prevention (CDC) as an ''urgent threat'' due to its ability to acquire and develop resistance to multiple classes of antibiotics. As a result, it is one of the most concerning pathogens in healthcare settings, wi...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2024-09-01
|
| シリーズ: | Journal of Global Antimicrobial Resistance |
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S2213716524001024 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|